Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Beyond safety, diabetes drugs offer CV benefits
• Experts push for change in fasting guidelines for lipid testing
• Insulin, GLP-1 receptor agonist combinations increase glycemic control without hypoglycemia, weight gain
• FDA advisory committee splits on CV benefit claim for Jardiance
• Autonomous thyroid nodule detected by molecular testing with next-generation sequencing Poorani Goundan, MBBS; Stephanie L. Lee, MD, PhD, ECNU
• Adrenal vein sampling, CT ‘imperfect’ tests to identify adrenalectomy candidates
• Adrenal volumes reduced, steroid hormone secretion increased after dexamethasone in PCOS
• Air pollution exposure linked to heart disease risk factors
• Analysis: Replacing saturated fat with linoleic acid may not confer mortality benefit
• Anaplastic thyroid cancer yields low remission, high recurrence rate after surgery
• BMD z scores similar in hypogonadotropic, hypergonadotropic hypogonadism
• BP elevations during pregnancy may raise risk for metabolic syndrome
• Denosumab reduces cortical porosity in women with postmenopausal osteoporosis
• Elevated late-night salivary cortisol may indicate recurrent Cushing’s disease
• Endocrine Society calls for stricter European regulation of EDCs
• Ethnicity affects TSH screening in UK newborns
• Forteo reduces nonvertebral fractures, increases BMD in type 2 diabetes, osteoporosis
• GH therapy increases fracture risk in patients previously treated for acromegaly
• GnRHa therapy shows no effect on final height in girls with early puberty
• Guideline: Risk for malignancy should determine treatment for adrenal incidentalomas
• HbA1c testing in ED targets undiagnosed diabetes, prediabetes
• Higher intake of whole grains may reduce risk for CVD mortality
• HPA axis activity increased in adolescent offspring of mothers with preeclampsia
• HT superior to oral contraceptives for increasing BMD in premature ovarian failure
• Insulin resistance linked to favorable bone microarchitecture after menopause
• Large initial weight loss mitigates CVD risk
• Long-term levothyroxine therapy does not affect arterial stiffness, central hemodynamics
• Medication adherence lapses with depressive symptoms in adolescents with type 2 diabetes
• Mexico’s acromegaly registry provides insight on treatment differences
• Microvascular disease increases risk for CV events in type 2 diabetes
• No link found between vitamin D status, type 2 diabetes risk in older men
• Plant-based diet may lower type 2 diabetes risk
• Prescribing patterns for compounded HT differ across specialties
• Recurrent DKA increases mortality risk in at-risk patients with diabetes
• RYGB superior to lifestyle-medical intervention alone for diabetes treatment
• Second gene expression test yields higher positive predictive value for thyroid malignancy
• Sexual dysfunction linked to metabolic syndrome in postmenopausal women
• Targeted acromegaly screening needed to improve outcomes, reduce complications
• Type 2 diabetes, prior CVD raise risk for CKD
• Uric acid likely marker of metabolic syndrome
• Urinary acetaminophen may indicate impaired fertility in men
• USPSTF screening criteria miss half of adults with diabetes, prediabetes
• Vaginal estradiol softgel capsule viable option for atrophy symptoms
• Weight gain over 1 year increases metabolic syndrome parameters in non-obese adults
• Younger age at HT initiation decreases CHD mortality risk
• ADA, IBM Watson Health collaborate on artificial intelligence initiative
• AHA metrics for heart health may translate to diabetes prevention in black adults
• Automated glucagon delivery reduces hypoglycemia in type 1 diabetes
• Bionic pancreas effective in home setting for reducing glucose, hypoglycemia
• Computerized IV insulin administration improves blood glucose control
• Bionic pancreas effective in home setting for reducing glucose, hypoglycemia
• Diabetes Collaborative Registry highlights real-world clinical management of patients with diabetes
• Lipids researcher receives AACE Frontiers in Science Award
• ‘Metabolic reproductive syndrome’ proposed as new name for PCOS
• Universal donor stem cells may hold answer to beta-cell transplantation barriers